Branding, Development, FDA Approval and Generic Pharmaceutical

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Branding

Development

FDA Approval

Generic Pharmaceutical

FDA Approves First Generic of Symbicort to Treat Asthma and COPD

The Pharma Data

MARCH 15, 2022

Agency Supports Development of Complex Generic Drug-Device Combination Product to Improve Competition and Access to More Affordable Medicines. The FDA regularly takes steps to help guide industry through the development process for generic drug products, including combination products, such as MDIs, that consist of a drug and a device.

FDA Approval

FDA Approval Generic Drugs Production Drugs

Novartis’ Sandoz Launches Biosimilars Awareness Campaign to Improve Biosimilars Adoption Worldwide

XTalks

JUNE 8, 2022

Sandoz is a pioneering leader in generic pharmaceuticals and biosimilars, as Sandoz launched the world’s first biosimilar in Europe in 2006 and won the first biosimilar approval in the US in 2014. Related: Cyltezo Becomes First FDA-Approved Interchangeable Humira Biosimilar.

Generic Pharmaceutical

Generic Pharmaceutical Branding Production Medicine

Clinical Research Informer

FDA Approves First Generic of Symbicort to Treat Asthma and COPD

Novartis’ Sandoz Launches Biosimilars Awareness Campaign to Improve Biosimilars Adoption Worldwide

Stay Connected